Internal Medicine, Hematology & Oncology · Bronx, NY
NPI
1467563296
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1200 Waters Pl, Suite M106
Bronx, NY, 10461
Phone (718) 823-9600
Groups this clinician bills Medicare through
Medicare paid, 2024
$827K
79,685 services
Medicare patients, 2024
378
Average age 75
Drug cost, 2024
$10.2M
2,057 prescriptions
Company payments, 2025
$82.73
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tarek Elrafei was code J1439 (injection, ferric carboxymaltose, 1 mg), 38,250 times for 34 patients. In total Tarek Elrafei billed 79,685 services in 166 codes, and Medicare paid $827K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-08-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 38,250 | 34 | $0.83 | $32K |
| 88185 Surgical Pathology Examination | Office | 2,393 | 73 | $22.03 | $53K |
| 36415 Venipuncture Blood Collection | Office | 979 | 328 | $8.65 | $8,468 |
| 85025 Blood Count | Office | 947 | 316 | $7.60 | $7,199 |
| 80053 Clinical Chemistry | Office | 758 | 294 | $10.35 | $7,845 |
| 99214 Office E&M - Established | Office | 597 | 214 | $108.30 | $65K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 514 | 15 | $0.09 | $43.86 |
| 84100 Clinical Chemistry | Office | 483 | 226 | $4.65 | $2,246 |
| 83615 Clinical Chemistry | Office | 461 | 209 | $5.92 | $2,729 |
| 83735 Clinical Chemistry | Office | 451 | 207 | $6.57 | $2,963 |
| 84550 Clinical Chemistry | Office | 443 | 206 | $4.43 | $1,962 |
| 82784 Immunoassay | Office | 408 | 73 | $9.11 | $3,718 |
| 82728 Clinical Chemistry | Office | 313 | 158 | $13.36 | $4,182 |
| 83540 Clinical Chemistry | Office | 310 | 157 | $6.34 | $1,965 |
| 83550 Clinical Chemistry | Office | 309 | 157 | $8.57 | $2,648 |
By year: 2022 $505K for 29,037 services; 2023 $1.0M for 61,573 services; 2024 $827K for 79,685 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88185 Surgical Pathology Examination | 2,393 | 73 | $22.03 | $53K |
| 36415 Venipuncture Blood Collection | 979 | 328 | $8.65 | $8,468 |
| 85025 Blood Count | 947 | 316 | $7.60 | $7,199 |
| 80053 Clinical Chemistry | 758 | 294 | $10.35 | $7,845 |
| 84100 Clinical Chemistry | 483 | 226 | $4.65 | $2,246 |
| 83615 Clinical Chemistry | 461 | 209 | $5.92 | $2,729 |
| 83735 Clinical Chemistry | 451 | 207 | $6.57 | $2,963 |
| 84550 Clinical Chemistry | 443 | 206 | $4.43 | $1,962 |
| 82784 Immunoassay | 408 | 73 | $9.11 | $3,718 |
| 82728 Clinical Chemistry | 313 | 158 | $13.36 | $4,182 |
Medicare prescription drug claims, 2024
In 2024, the drug Tarek Elrafei prescribed most often to Medicare patients was Aranesp (Darbepoetin Alfa In Polysorbat), with 166 prescriptions and refills. In total Tarek Elrafei wrote 2,057 Medicare prescriptions that cost $10.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Aranesp Darbepoetin Alfa In Polysorbat | 166 | 166 | 27 | $405K |
| Procrit Epoetin Alfa | 88 | 88 | 11 | $150K |
| Akynzeo Fosnetupitant/Palonosetron | 83 | 83 | 20 | $83K |
| Letrozole Generic | 83 | 159 | 25 | $1,429 |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 72 | 72 | Under 11 | $379K |
| Eliquis Apixaban | 64 | 105 | 16 | $58K |
| Revlimid Lenalidomide | 63 | 63 | Under 11 | $990K |
| Lupron Depot Leuprolide Acetate | 54 | 167 | 20 | $313K |
| Xarelto Rivaroxaban | 47 | 59 | Under 11 | $32K |
| Prednisone Generic | 40 | 46 | 14 | $162 |
| Darzalex Faspro Daratumumab-Hyaluronidase-Fihj | 38 | 38 | Under 11 | $817K |
| Neulasta Onpro Pegfilgrastim | 38 | 38 | Under 11 | $227K |
| Pomalyst Pomalidomide | 37 | 37 | Under 11 | $766K |
| Gabapentin Generic | 33 | 44 | 12 | $208 |
| Dexamethasone Generic | 33 | 39 | 13 | $305 |
Brand drugs: 1,240 claims; generic drugs: - claims; opioid claims: 49.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tarek Elrafei $82.73 ($82.73 in general payments such as food, travel and fees) from 3 companies. The largest payer was Pfizer Inc. with $34.75.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.